Over the past two decades, there has been a steady increase in knowledge associated with the clinical manifestations of cholestatic liver disease. Based on these clinical situations, this book provides useful and timely information on the ever-expanding subject of cholestatic liver disease. It supplies scientific updates from leading experts which relate to the clinical evaluation and management of cholestatic liver disorders.
Recenzijas
From the reviews: "This 10-chapter book provides a ... review of the clinical evaluation and management of cholestatic liver disorders. ... An extensive list of references accompanies each section. ... The editors and authors are highly respected experts in their field, and their extensive clinical experience is evident. ... Recommended Readership: students, residents, fellows, and attending physicians with interests in gastroenterology and hepatology." (Emma Culver, Mayo Clinic Proceedings, Vol. 82 (11), November, 2008) "The goal of this book is to provide scientific updates from leading experts which relate to the clinical evaluation and management of cholestatic liver disorders. The book is good for doctors which are not used to seeing many cholestatic patients, but also for hepatologists who wish to have a quick review of the literature. ... This book 'Cholestatic Liver Disease', gives a complete overview of most important cholestatic diseases. ... the book is easy to read and is suitable for clinicians." (Isabelle Colle, Acta Clinica Belgica, Vol. 64 (1), December, 2009)
Chapter Titles Topics to Cover Author Information
1. Diagnosis of
cholestasis Liver tests/antibodies Cross-sectional studies Liver biopsy MRCP,
ERCP, CT Cholangiogram, EUS Velimir Luketic, M.D. Virginia Commonwealth
University 804-828-4060-P vluketic@hsc.vcu.edu
2. Drug-induced cholestasis
Include herbal remedies Jacqueline Laurin, M.D. University of Maryland
410-328-1358-P jlaurin@medicine.umaryland.edu
3. PBC Usual (overlap and
recurrence after transplant covered elsewhere) Cynthia Levy, M.D. University
of Florida 352-392-6002-P levyc@medicine.ufl.edu
4. PSC Usual (overlap and
recurrence after transplant covered elsewhere) Risk of colon CA with IBD,
colon CA post-transplant, and cholangiocarcinoma Kelly Burak, M.D. University
of Calgary 403-210-9363 kwburak@ucalgary.ca
5. Overlap Syndrome with
autoimmune hepatitis PBC/AIH PSC/AIH Alastair Smith, M.B. Duke University
Medical Center 919-681-4044-P alastair.smith@duke.edu
6. Rare causes of
cholestasis (genetic disorders) BRIC, Dubin Johnson Byler, Rotor, etc.
Konstantinos Lazaridis, M.D. Mayo Clinic 507-284-1006-P
lazaridis.konstantinos@mayo.edu
7. Cholestatic variants of alcohol, viral
disease Alcohol Hepatitis (viral) Jeffrey Crippin, M.D. Washington University
314-454-8160-P jcrippin@wustl.edu
8. Cholestasis from systemic disorders
Sarcoid, lymphoma, granulomatous disease, cystic fibrosis, rheumatologic
diseases David Kaplan, M.D. University of Pennsylvania 215-823-5800-P
dakaplan@mailmed.upenn.edu
9. Complications of cholestasis Osteoporosis
Pruritus Lipids Marlyn Mayo, M.D. University of Texas Southwestern
214-648-3444-P marlyn.mayo@utsouthwestern.edu
10. Cholestasis post
transplantation Drugs, strictures, viral disease, recurrent cholestatic liver
disease Timothy McCashland, M.D. University of Nebraska 402-559-8859-P
tmccashland@unmc.edu